Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

8-Cl-adenosine induces differentiation in LS174T cells.

C C Carlson1, L L Burnham, R A Shanks

  • 1Department of General Surgery, Medical College of Georgia, Atlanta 30912, USA [corrected].

Digestive Diseases and Sciences
|May 2, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prenatal exposure to psychostimulants increases impulsivity, compulsivity, and motivation for rewards in adult mice.

Physiology & behavior·2013
Same author

Amphetamine and methamphetamine have a direct and differential effect on BV2 microglia cells.

Bulletin of experimental biology and medicine·2013
Same author

A distinct strategy to generate high-affinity peptide binders to receptor tyrosine kinases.

Protein engineering, design & selection : PEDS·2005
Same author

8-Cl-adenosine induces growth arrest without differentiation of primary mouse epidermal keratinocytes.

The Journal of investigative dermatology·2002
Same author

PI3-kinase/Akt modulates vascular smooth muscle tone via cAMP signaling pathways.

Journal of applied physiology (Bethesda, Md. : 1985)·2001
Same author

8-Cl-adenosine-induced inhibition of colorectal cancer growth in vitro and in vivo.

Neoplasia (New York, N.Y.)·2001

8-Cl-adenosine effectively inhibits colorectal cancer cell growth by halting the cell cycle and promoting differentiation. This novel agent, 8-Cl-adenosine, shows promise as a non-toxic chemotherapeutic for colorectal cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Colorectal cancer (CRC) remains a significant global health challenge.
  • Novel chemotherapeutic agents are needed to improve treatment outcomes.
  • 8-Cl-adenosine has shown potential as a growth inhibitor for various cancer cell lines.

Purpose of the Study:

  • To investigate the growth inhibitory effects of 8-Cl-adenosine on the LS174T colorectal cancer cell line.
  • To determine the mechanism of growth inhibition, including cell cycle effects and differentiation.
  • To assess the role of 8-Cl-adenosine independently of its precursor, 8-Cl-cAMP.

Main Methods:

  • Treatment of LS174T cells with 8-Cl-adenosine.
  • Analysis of cell cycle progression using protein level assessments (p21WAF1/Cip1, p53, retinoblastoma protein phosphorylation).

Related Experiment Videos

  • Evaluation of enterocytic differentiation markers (villin protein, alkaline phosphatase activity).

    • Main Results:

    • 8-Cl-adenosine inhibited LS174T cell growth by inducing a G1 cell cycle arrest.
    • Significant increases in p21WAF1/Cip1 and p53 protein levels were observed.
    • Treatment led to increased villin protein and alkaline phosphatase activity, indicating enterocytic differentiation.
    • No apoptosis was induced in LS174T cells.

    Conclusions:

    • 8-Cl-adenosine is a potent inhibitor of colorectal cancer cell growth.
    • The mechanism involves G1 cell cycle arrest and induction of enterocytic differentiation.
    • 8-Cl-adenosine represents a promising non-toxic chemotherapeutic agent for colorectal cancer.